circle c ranch semaglutide weight loss AlphaMeD Direct Primary Care Moving to Circle C, Austin
Description
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
Ozempic is not licensed in the UK
GLP-1 agonists such as semaglutide (marketed as Ozempic and Wegovy) have surged
The Global GLP-1 Agonist Market, valued at USD 28.13B in 2024, is projected to reach USD 133.35B by 2030, growing at a 29.6% CAGR.
Revision Skincare does not manufacture Semaglutides
Moreover, the medical device industry is facing its own set of uncertainties
